Environmental protection and credible sustainability are scaling the global social agenda and the corporate world is not standing by. Reducing emissions and waste are now a key part of business strategy across a number of sectors, and pharmaceutical and medical device manufacturers are not excluded. There are in fact, various benefits that can be achieved in addition to compliance with new demands by regulators, hospital systems, governments and consumers to conform to this emerging reality. In addition, companies are well aware that if they do not introduce measures to become more environmentally responsible, they will risk losing access to markets around the world.
A Sizeable Problem
The U.S. healthcare system accounts for 10% of the country’s carbon emissions and 9% of harmful non-greenhouse air pollutants , while the combined healthcare sectors of the United States, Australia, Canada, and England produce about 748 million metric tons of greenhouse gases annually.1 In Europe, legislation has been introduced to help curb these figures, while in the United States, pressure from a non-domestic customer base has already forced many U.S. companies to comply with the Waste Electrical and Electronic Equipment (WEEE) and Restriction on Hazardous Substances (RoHS) directives. In addition, many commentators are now saying they regard the passage of strict environmental regulation and/or legislation in the United States as inevitable. . .
Visit MedTechIntelligence.com for the full article.